The Volpara Health Technologies Ltd (ASX: VHT) share price is heading south today regardless of the company's significant positive announcement.
At the time of writing, the healthcare technology company's shares are down 2.54% to $1.15.
Volpara secures largest-ever contract
According to the company's announcement, Volpara advised it has signed its biggest contract to date with a leading US outpatient diagnostic imaging provider.
The five-year deal is valued at US$2.15 million which represents an annual recurring revenue (ARR) of US$430,000.
Under the agreement, Volpara will install its Patient Hub software across the customer's network of imaging centres. The software solution is expected to provide a standardised patient tracking platform that incorporates Volpara Risk and Scorecard.
As such, this will enable the customer to accurately decide the appropriate personalised breast cancer screening pathway for each patient.
Volpara estimates that at least one of its software products is used in the breast cancer screening of more than 33% of women in the US.
Whilst the announcement is extremely positive, it appears the broader All Ordinaries Index (ASX: XAO) is weighing down the Volpara share price. The index is currently down 0.90% to 7,508.7 points.
Volpara group CEO Dr Ralph Highnam commented:
While we would not normally announce individual deals, this is Volpara's highest-value contract signed to date.
We are experiencing tremendous momentum for our platform in the market as we bring together best-of-breed patient tracking, risk assessment, and density scoring to allow our customers to provide their patients with the individualised care they deserve.
Our platform provides both Volpara and our customers with a significant advantage and is enabling us to seek out opportunities that did not exist even a couple of years ago.
About the Volpara share price
The past 12 months have been disappointing for investors with the company's shares down 13%. Year-to-date, their losses are further magnified, almost 20% lower over the period.
Based on today's price, Volpara presides a market capitalisation of roughly $29 million and has approximately 251.3 million shares outstanding.
